These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 4000717)

  • 21. Pentasaccharide and Orgaran arrest, whereas heparin delays thrombus formation in a rat arteriovenous shunt.
    Vogel GM; van Amsterdam RG; Kop WJ; Meuleman DG
    Thromb Haemost; 1993 Jan; 69(1):29-34. PubMed ID: 8446935
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heparin-associated thrombocytopenia: successful therapy with the heparinoid Org 10172 in a patient showing cross-reaction to LMW heparins.
    Greinacher A; Drost W; Michels I; Leitl J; Gottsmann M; Kohl HJ; Glaser M; Mueller-Eckhardt C
    Ann Hematol; 1992 Jan; 64(1):40-2. PubMed ID: 1310879
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The anticoagulant effect of heparinoid Org 10172 during haemodialysis: an objective assessment.
    Ireland H; Lane DA; Flynn A; Anastassiades E; Curtis JR
    Thromb Haemost; 1986 Apr; 55(2):271-5. PubMed ID: 3715791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relative efficacy of heparin and related glycosaminoglycans as antithrombotic drugs.
    Thomas DP; Merton RE; Barrowcliffe TW
    Ann N Y Acad Sci; 1989; 556():313-22. PubMed ID: 2735662
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of two experimental thrombosis models in rats effects of four glycosaminoglycans.
    Vogel GM; Meuleman DG; Bourgondiën FG; Hobbelen PM
    Thromb Res; 1989 Jun; 54(5):399-410. PubMed ID: 2549654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ORG 10172: a low molecular weight heparinoid anticoagulant with a long half-life in man.
    Bradbrook ID; Magnani HN; Moelker HC; Morrison PJ; Robinson J; Rogers HJ; Spector RG; Van Dinther T; Wijnand H
    Br J Clin Pharmacol; 1987 Jun; 23(6):667-75. PubMed ID: 3606928
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Successful use of the APTT in monitoring of the anti-factor Xa activity of the heparinoid organon 10172 in a case of HITS requiring open heart surgery.
    Marshall LR; Cannell PK; Herrmann RP
    Thromb Haemost; 1992 May; 67(5):587. PubMed ID: 1519220
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical use of heparin fractions, fragments, and heparinoids.
    Messmore HL
    Semin Thromb Hemost; 1985 Apr; 11(2):208-12. PubMed ID: 2412297
    [No Abstract]   [Full Text] [Related]  

  • 29. Heparin-induced thrombocytopenia: studies with a new low molecular weight heparinoid, Org 10172.
    Chong BH; Ismail F; Cade J; Gallus AS; Gordon S; Chesterman CN
    Blood; 1989 May; 73(6):1592-6. PubMed ID: 2713496
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effectiveness of a low molecular weight heparinoid in chronic intermittent haemodialysis.
    Henny CP; ten Cate H; Surachno S; Stevens P; Büller HR; den Hartog M; ten Cate JW
    Thromb Haemost; 1985 Aug; 54(2):460-2. PubMed ID: 2417351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Different antithrombotic mechanisms among glycosaminoglycans revealed with a new fucosylated chondroitin sulfate from an echinoderm.
    Pacheco RG; Vicente CP; Zancan P; Mourão PA
    Blood Coagul Fibrinolysis; 2000 Sep; 11(6):563-73. PubMed ID: 10997797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Haemofiltration/haemodialysis in patients with heparin-associated thrombocytopenia.
    Chong BH; Jacques T
    Intensive Care Med; 1991; 17(7):437. PubMed ID: 1774405
    [No Abstract]   [Full Text] [Related]  

  • 33. Inhibition of the early stages of the thrombin generation reaction by various glycosaminoglycans.
    Visser A; Meuleman DG
    Thromb Res; 1990 Jun; 58(5):469-79. PubMed ID: 2164263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The relative importance of thrombin inhibition and factor Xa inhibition to the antithrombotic effects of heparin.
    Buchanan MR; Boneu B; Ofosu F; Hirsh J
    Blood; 1985 Jan; 65(1):198-201. PubMed ID: 3965047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Large-dose infusions of heparinoid ORG 10172 in ischemic stroke.
    Massey EW; Biller J; Davis JN; Adams HP; Marler JR; Goldstein LB; Alberts M; Bruno A
    Stroke; 1990 Sep; 21(9):1289-92. PubMed ID: 2396265
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gastrointestinal blood loss in haemodialysis patients during use of a low-molecular-weight heparinoid anticoagulant.
    Frei U; Wilks MF; Boehmer S; Crisp-Lindgren N; Schwarzrock R; Stiekema JC; Koch KM
    Nephrol Dial Transplant; 1988; 3(4):435-9. PubMed ID: 2459635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Orgaran in the prevention of deep vein thrombosis in stroke patients.
    Turpie AG
    Haemostasis; 1992; 22(2):92-8. PubMed ID: 1379969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early clinical experience of a new heparinoid, Org 10172, in prevention of deep venous thrombosis.
    Cade JF; Wood M; Magnani HN; Westlake GW
    Thromb Res; 1987 Mar; 45(5):497-503. PubMed ID: 3590088
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Heparin-induced thrombopenia during hemodialysis in intensive care: use of a low molecular weight heparinoid, ORG 10172 (Orgaran)].
    Mahul P; Raynaud J; Favre JP; Jospé R; Décousus H; Auboyer C
    Ann Fr Anesth Reanim; 1995; 14(1):29-32. PubMed ID: 7677282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects on platelets and on the clotting system of four glycosaminoglycans extracted from hog mucosa and one extracted from aortic intima of the calf.
    Cella G; Scattolo N; Luzzatto G; Stevanato F; Vio C; Girolami A
    J Med; 1986; 17(5-6):331-46. PubMed ID: 2953835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.